Viewing Study NCT02261220


Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2025-12-26 @ 3:16 AM
Study NCT ID: NCT02261220
Status: COMPLETED
Last Update Posted: 2020-03-06
First Post: 2014-10-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors
Sponsor: MedImmune LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module